UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001866
Receipt number R000002247
Scientific Title Continuous intravenous infusion therapy with cyclosporine A for rapidly progressive interstitial pneumonia associated with dermatomyositis and polymyositis
Date of disclosure of the study information 2009/04/10
Last modified on 2019/10/20 15:55:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Continuous intravenous infusion therapy with cyclosporine A for rapidly progressive interstitial pneumonia associated with dermatomyositis and polymyositis

Acronym

Continuous intravenous infusion therapy with cyclosporine A for rapidly progressive interstitial pneumonia associated with dermatomyositis and polymyositis

Scientific Title

Continuous intravenous infusion therapy with cyclosporine A for rapidly progressive interstitial pneumonia associated with dermatomyositis and polymyositis

Scientific Title:Acronym

Continuous intravenous infusion therapy with cyclosporine A for rapidly progressive interstitial pneumonia associated with dermatomyositis and polymyositis

Region

Japan


Condition

Condition

Dermatomyositis or polymyositis with interstitial pneumonia

Classification by specialty

Neurology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate therapeutic efficacy of continuous intravenous infusion of cyclosporine A (CyA) for rapidly progressive interstitial pneumonia (IP) associated with dermatomyositis (DM) and/or polymyositis (PM)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Clinical symptoms, Respiratory functional evaluation, Chest CT and X-ray, Blood examinations

Key secondary outcomes

To evaluate long-term prognosis
To establish an effective therapeutic strategy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

(1)The patients are initially treated with methylprednisolone (m-PSL) pulse (1000 mg daily for three days) followed by oral prednisolone (1mg/kg daily).
(2)Continuous intravenous CyA (2 mg/kg daily for initial dose) is started following m-PSL pulse therapy, and the dosage will be adjusted to a level of 200-300ng/ml.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

In addition of fulfilling diagnostic criteria for DM/PM or clinically amyopathic DM and the presence of IP on chest X-ray and/or CT, one or more of the following clinical findings are necessary ; (1) %VC is lower than 80%, (2) % DLCO is lower than 70%, (3) acute respiratory symptoms (dyspnea, dry cough), (4) PaO2 is lower than 70mmHg.

Key exclusion criteria

We exclude patients with active infectious disease, severe renal dysfunction and malignancy.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuhiro Shimojima

Organization

Shinshu University School of Medicine

Division name

Department of Neurology and Rheumatology

Zip code


Address

3-1-1 Asahi, Matsumoto, Japan

TEL

0263-37-2673

Email

yshimoji@shinshu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuhiro Shimojima

Organization

Shinshu University School of Medicine

Division name

Department of Neurology and Rheumatology

Zip code


Address

3-1-1 Asahi, Matsumoto, Japan

TEL

0263-37-2673

Homepage URL


Email

yshimoji@shinshu-u.ac.jp


Sponsor or person

Institute

Department of Neurology and Rheumatology, Shinshu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Shinshu University School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 04 Month 10 Day

Date of IRB

2009 Year 04 Month 07 Day

Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2012 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 04 Month 10 Day

Last modified on

2019 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002247


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name